ENTITY

Instil Bio (TIL US)

5
Analysis
Health CareUnited States
Instil Bio, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing cell therapy pipeline of autologous tumor infiltrating lymphocyte and for the treatment of patients with cancer. Instil Bio serves customers worldwide.
more
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x